Based on data from the past 90 days ending February 07, 2026, Terns Pharmaceuticals's three largest insider shareholders are Director Carl L Gordon (755.63K shares), Director Advisors Llc Orbimed (755.63K shares), TenPercentOwner Biosciences Fund V, L.P. Lav (529.76K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Advisors Llc Orbimed | 755,635 | 17 Jul, 2024 | |
| Carl L Gordon | 755,635 | 17 Jul, 2024 | |
| Biosciences Fund V, L.P. Lav | 529,762 | 28 Nov, 2022 | |
| Hongbo Lu | 476,190 | 17 Sep, 2024 | |
| Amy L. Burroughs | Chief Executive Officer | 288,976 | 16 Jan, 2026 |
| Opportunity, Llc Vivo | 268,573 | 03 Apr, 2024 | |
| Emil Kuriakose | Chief Medical Officer | 106,615 | 16 Jan, 2026 |
| Andrew Gengos | Chief Financial Officer | 101,788 | 16 Jan, 2026 |
| Seokho Bryan Yoon | Coo And General Counsel | 91,940 | 04 Jun, 2024 |
| Erin Quirk | President And Head Of R&D | 75,000 | 25 Jan, 2024 |
| Mark J. Vignola | Chief Financial Officer | 74,752 | 06 Jan, 2025 |
| Senthil Vel Sundaram | Chief Executive Officer | 9,770 | 02 Jun, 2023 |
| Melita Sun Jung | Chief Business Officer | 2,250 | 03 Feb, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 15 Jan, 2026 | Amy L. Burroughs | Common Stock | A | 27,083 | $4.64 | 316,059 | D | M |
| 15 Jan, 2026 | Amy L. Burroughs | Common Stock | D | 61,228 | $37.02 | 296,497 | D | S |
| 15 Jan, 2026 | Amy L. Burroughs | Common Stock | A | 14,583 | $4.64 | 357,725 | D | M |
| 15 Jan, 2026 | Amy L. Burroughs | Common Stock | A | 27,083 | $4.64 | 343,142 | D | M |
| 15 Jan, 2026 | Amy L. Burroughs | Common Stock | D | 7,521 | $37.53 | 288,976 | D | S |
| 14 Jan, 2026 | Andrew Gengos | Common Stock | A | 68,750 | $0.00 | 101,788 | D | A |
| 14 Jan, 2026 | Amy L. Burroughs | Common Stock | A | 150,000 | $0.00 | 288,976 | D | A |
| 14 Jan, 2026 | Emil Kuriakose | Common Stock | A | 56,250 | $0.00 | 106,615 | D | A |
| 05 Jan, 2026 | Amy L. Burroughs | Common Stock | A | 150,000 | - | 210,315 | D | M |
| 05 Jan, 2026 | Amy L. Burroughs | Common Stock | D | 71,339 | $38.10 | 138,976 | D | S |
| 02 Jan, 2026 | Amy L. Burroughs | Common Stock | A | 21,551 | $4.64 | 60,315 | D | M |
| 02 Jan, 2026 | Emil Kuriakose | Common Stock | D | 200 | $39.60 | 51,320 | D | S |
| 02 Jan, 2026 | Emil Kuriakose | Common Stock | D | 955 | $38.36 | 50,365 | D | S |
| 04 Nov, 2025 | Jill M. Quigley | Common Stock | D | 24,520 | $18.00 | 0 | D | S |
| 04 Nov, 2025 | Jill M. Quigley | - | - | 24,520 | D | |||
| 04 Nov, 2025 | Jill M. Quigley | Common Stock | A | 24,520 | $9.24 | 24,520 | D | M |
| 04 Nov, 2025 | Jill M. Quigley | - | - | 0 | D | |||
| 01 Oct, 2025 | Emil Kuriakose | Common Stock | D | 944 | $7.85 | 51,520 | D | S |
| 01 Jul, 2025 | Emil Kuriakose | Common Stock | D | 853 | $4.27 | 52,464 | D | S |
| 27 Jun, 2025 | Andrew Gengos | Common Stock | A | 5,000 | $3.93 | 20,000 | D | P |